RNN Key Stats
- Market Wrap: Men's Wearhouse/Jos. A. Bank Strike Deal; Fuel Cell Stocks Pop, Drop; Bye, Bye Fannie and Freddie? Street Insider 03/11 17:14 ET
- Rexahn Pharma (RNN) Reports MTD Not Yet Achieved in Supinoxin Phase I Street Insider 03/11 08:04 ET
- Rexahn Pharmaceuticals (RNN) Stock Hit Street Insider 03/07 08:42 ET
- Biotech Stock Mailbag: Exact Sciences, Rexahn, Advaxis, Peregrine The Street 03/07 01:00 ET
- Rexahn Pharmaceuticals to Present at the 26th Annual ROTH Conference Business Wire 03/04 08:00 ET
- REXAHN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Yahoo 03/03 16:16 ET
- Rexahn Pharmaceuticals Appoints Mark Carthy to Board of Directors Business Wire 03/03 08:00 ET
- Rexahn Pharmaceuticals: Another $1.30 Biotech Lottery Ticket Yahoo 02/27 12:14 ET
- Rexahn Pharmaceuticals, Inc. (RNN) Stock Hit Street Insider 02/10 14:39 ET
- 5 Stocks Under $10 Set to Soar The Street 02/06 10:18 ET
RNN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Rexahn Pharmaceuticals is up 296.9% over the last year vs S&P 500 Total Return up 24.21%, Advaxis down 57.60%, and Emergent BioSolutions up 75.27%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for RNN
Pro Strategies Featuring RNN
Did Rexahn Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: Maryland
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Rexahn Pharmaceuticals, Inc., is a development stage biopharmaceutical company engaged in the development of novel treatments for cancer to patients.